Stand Down IX: Is the Country Headed Into a Global Depression? Ray Dalio.
Q: Do you think we're headed into a global depression?
A: Well, yes, but I want to be careful. The word is an evocative word...
https://youtu.be/yrxYhv2O3wU?t=514
TeleHealths’ Screaming Growth in Canada.
"Dialogue says it has also seen a surge of customer interest, with 100 companies subscribing to its annual service in the past two weeks,...
SEC takes enforcement action against 23 companies for claims relating to COVID-19.
Aint Nothing but a Gangter Party.
Like cryptocurrency and cannabis, the coronavirus pandemic may attract fraudsters keen to profit off demand for tests and treatments...
Biotech Stock Review: Mitesco (MITI) $0.03, Report Update
Mitesco to Launch Telehealth Enabled Primary Care Clinic Business with Q4 Rollout Addressing Healthcare Backlog Accentuated by the Second Wave Concerns.
REPORT UPDATE:
Denver, CO, May...
Update: Biotech 5 Pack. 5 Biotech Stocks, we Expected to Double in 2020.
No Doubles Yet, But They're Doing Rather Well, Considering Everything. Our Confidence Remains Unwavered. Best Performer up 63%.
IN ORDER OF SHARE PRICE..LOW TO HIGH
Mitesco...
Citius Pharma (CTXR) Seeks Expeditious Pathway Into the Clinic, for CoronaVirus Related Acute Respiratory...
Sumbmits pre-IND Into Coronavirus Treatment Acceleration Program (CTAP).
Citius Announces Pre-IND Submission to FDA Under the Coronavirus Treatment Acceleration Program for a Novel Stem...
True Nature | Mitesco (MITI) Raising $15 Million.
LIVE CHART
Mitesco, Inc. Announces up to $15 Million Unit Preferred Capital Raise
Mitesco (formerly known as True Nature) is gaining steam since announcing they engaged...
Immunomedics (IMMU) up 100% Today or $2 Billion in Value.
Again as mentioned a few weeks ago, our bearish market opinion is related to large-caps and large-cap funds and ETF's. If you find a small company whose...
European Hand Sanitizer Market Expected to Reach $9.4 Billion by 2027.
Growing at a CAGR of 38.4% during 2019–2027.
The European hand sanitizer market was valued at US$ 641.7 million in 2018 and is expected to...
Revive Therapeutics Announces Entry Into Phase III FDA Trial Using Glutathione Boosting Bucillamine.
Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial
TORONTO, April 23, 2020 (GLOBE NEWSWIRE) --Revive Therapeutics Ltd.Ltd....















